Table 2

Total deposition (Dt), peripheral deposition (Dp), and time required to inhale 50 mg of α1‐protease inhibitor (T50) measured in six patients with α1‐protease inhibitor deficiency after inhalation with different devices

DeviceDt %Dp %T50 min
HaloLite59±7 (12)33±10 (30)99±41 (41)
LC Star®52±17 (33)34±19 (56)44±25 (57)
AKITA® Sidestream®75±8 (11)53±11 (21)24±13 (54)
AKITA® LC Star®80±7 (9)57±9 (16)18±6 (13)
  • Data are presented as mean±sd (coefficient of variation=100×sd/mean)